Brian S. Chang

3.7k total citations · 2 hit papers
9 papers, 3.1k citations indexed

About

Brian S. Chang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Brian S. Chang has authored 9 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 1 paper in Surgery. Recurrent topics in Brian S. Chang's work include Cell death mechanisms and regulation (7 papers), RNA Interference and Gene Delivery (3 papers) and Cancer-related Molecular Pathways (3 papers). Brian S. Chang is often cited by papers focused on Cell death mechanisms and regulation (7 papers), RNA Interference and Gene Delivery (3 papers) and Cancer-related Molecular Pathways (3 papers). Brian S. Chang collaborates with scholars based in United States, Germany and Canada. Brian S. Chang's co-authors include Craig B. Thompson, John E. Harlan, Stephen W. Fesik, Robert Meadows, Ho Sup Yoon, David G. Nettesheim, Heng Liang, Michael Sattler, Matthias Eberstadt and Suzanne B. Shuker and has published in prestigious journals such as Nature, Science and The EMBO Journal.

In The Last Decade

Brian S. Chang

9 papers receiving 3.0k citations

Hit Papers

Structure of Bcl-x L -Bak Peptide Complex: Recognition Be... 1996 2026 2006 2016 1997 1996 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian S. Chang United States 8 2.7k 551 482 243 200 9 3.1k
Matthias Eberstadt United States 11 1.9k 0.7× 325 0.6× 371 0.8× 144 0.6× 165 0.8× 12 2.2k
William T. Windsor United States 23 1.5k 0.5× 876 1.6× 370 0.8× 169 0.7× 97 0.5× 42 2.5k
Robert A. Aldape United States 12 1.7k 0.6× 370 0.7× 535 1.1× 146 0.6× 141 0.7× 13 2.3k
Carlo M. Nalin United States 23 2.3k 0.8× 531 1.0× 229 0.5× 165 0.7× 160 0.8× 29 2.8k
Min-Jung Lee United States 28 1.8k 0.7× 663 1.2× 392 0.8× 138 0.6× 234 1.2× 96 2.8k
Stuart L. Schreiber United States 12 2.3k 0.8× 638 1.2× 615 1.3× 130 0.5× 86 0.4× 12 2.7k
Christophe Briand Switzerland 20 1.9k 0.7× 550 1.0× 412 0.9× 225 0.9× 160 0.8× 29 2.6k
Thomas O’Brien United States 31 2.7k 1.0× 743 1.3× 225 0.5× 258 1.1× 337 1.7× 62 3.6k
Eric N. Shiozaki United States 10 2.3k 0.8× 412 0.7× 425 0.9× 427 1.8× 240 1.2× 10 2.5k
Alexey Stukalov Austria 17 1.5k 0.5× 323 0.6× 312 0.6× 186 0.8× 252 1.3× 36 2.1k

Countries citing papers authored by Brian S. Chang

Since Specialization
Citations

This map shows the geographic impact of Brian S. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian S. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian S. Chang more than expected).

Fields of papers citing papers by Brian S. Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian S. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian S. Chang. The network helps show where Brian S. Chang may publish in the future.

Co-authorship network of co-authors of Brian S. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Brian S. Chang. A scholar is included among the top collaborators of Brian S. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian S. Chang. Brian S. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Chang, Brian S., Tao Yang, Edmund S. Cibas, & Jonathan A. Fletcher. (2007). An in vitro cytologic assay for evaluation of the KIT signaling pathway in gastrointestinal stromal tumors. Modern Pathology. 20(5). 579–583. 8 indexed citations
2.
Chang, Brian S., Geraldine S. Pinkus, & Edmund S. Cibas. (2006). Exfoliated Endometrial Cell Clusters in Cervical Cytologic Preparations Are Derived From Endometrial Stroma and Glands. American Journal of Clinical Pathology. 125(1). 77–81. 4 indexed citations
3.
Burri, Stuart H., Caryn N. Kim, Guofu Fang, et al.. (1999). ‘loop’ domain deletional mutant of Bcl-xL is as effective as p29Bcl-xL in inhibiting radiation-induced cytosolic accumulation of cytochrome c (cyt c), caspase-3 activity, and apoptosis. International Journal of Radiation Oncology*Biology*Physics. 43(2). 423–430. 10 indexed citations
4.
Chang, Brian S., Ameeta Kelekar, Marian H. Harris, et al.. (1999). The BH3 Domain of Bcl-xS Is Required for Inhibition of the Antiapoptotic Function of Bcl-xL. Molecular and Cellular Biology. 19(10). 6673–6681. 38 indexed citations
5.
Fang, Guofu, Brian S. Chang, Caryn N. Kim, et al.. (1998). "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.. PubMed. 58(15). 3202–8. 103 indexed citations
6.
Chang, Brian S.. (1997). Identification of a novel regulatory domain in Bcl-xL and Bcl-2. The EMBO Journal. 16(5). 968–977. 242 indexed citations
7.
Kelekar, Ameeta, Brian S. Chang, John E. Harlan, Stephen W. Fesik, & Craig B. Thompson. (1997). Bad Is a BH3 Domain-Containing Protein That Forms an Inactivating Dimer with Bcl-X L. Molecular and Cellular Biology. 17(12). 7040–7046. 237 indexed citations
8.
Sattler, Michael, Heng Liang, David G. Nettesheim, et al.. (1997). Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis. Science. 275(5302). 983–986. 1211 indexed citations breakdown →
9.
Muchmore, Steven W., Michael Sattler, Heng Liang, et al.. (1996). X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 381(6580). 335–341. 1199 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026